AlzChem Group AG (ACT)
XETR
Real-time Data
07:00 AM
Day's Range
158.5052 wk Range
123.20Overview - ACT - AlzChem Group AG
Key Statistics
Valuation
Enterprise Value
1.64B
P/E (Trailing)
‪23.88‬
P/E (Forward)
‪19.18‬
PEG Ratio
‪1.56‬
Price / Sales (TTM)
‪4.32‬
Price / Book
‪6.00‬
EV / EBITDA
‪34.83‬
Profitability
Gross Margin
‪69.06%‬
Profit Margin
‪5.84%‬
Operating Margin
‪14.88%‬
Return on Assets
‪10.27%‬
Return on Equity
‪24.57%‬
Ownership
Shares Outstanding
10.12M
Float
4.83M
Held by Insiders
‪31.93%‬
Held by Institutions
‪49.70%‬
Price stats
50-Day Avg
‪170.81‬
200-Day Avg
‪162.42‬
Dividends
Payout Ratio
‪31.34%‬
Frequency
Annual
Analyst Consensus
8 analysts
Average price target
‪€ 205.81‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ACT - AlzChem Group AG
Peers - ACT - AlzChem Group AG
Peer Comparison
Compared with companies in Specialty Chemicals listed on XETR.
Profile Summary - ACT - AlzChem Group AG
About
AlzChem Group AG is a vertically integrated specialty chemicals company with roots dating back to 1908, renowned for its leadership in niche markets including Health & Pharma, Human & Animal Nutrition, Renewable Energies, Agriculture, Metallurgy, Fine Chemistry, Automotive & Defense, and Custom Manufacturing. The…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
